Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

dc.date.accessioned	2020-10-21T06:45:17Z
dc.date.available	2020-10-21T06:45:17Z
dc.date.issued	2017
dc.date.issued	2017/03/24
dc.identifier.citation	Yıldız İ, Bilici A, Ucar M.Cancer Invest. 2017 Apr 21;35(4):248-255. doi: 10.1080/07357907.2017.1292518. Epub 2017 Mar 23.
dc.identifier.uri	http://doi.org/10.1080/07357907.2017.1292518
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71545
dc.description	PMID = 28333566
dc.relation.isversionof	10.1080/07357907.2017.1292518
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study
dc.type	article
dc.relation.journal	Cancer Invest
dc.identifier.doi	10.1080/07357907.2017.1292518
dc.contributor.author	Bilir C
dc.contributor.author	Yıldız İ
dc.contributor.author	Bilici A
dc.contributor.author	Ucar M
dc.contributor.author	Berk V
dc.contributor.author	Yıldız Y
dc.contributor.author	Yazıcı O
dc.contributor.author	İmamoğlu Gİ
dc.contributor.author	Karadurmuş N
dc.contributor.author	Pilancı KN
dc.contributor.author	Arpacı E
dc.contributor.author	Tanrıverdi Ö
dc.contributor.author	Karcı E
dc.contributor.author	Temiz S
dc.contributor.author	Nayır E
dc.contributor.author	Oktay E
dc.contributor.author	Dal P
dc.contributor.author	Petekkaya İ
dc.contributor.author	Varım C
dc.contributor.author	Cinemre H.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi